Relevant conflicts of interest/financial disclosures: Nothing to report. Full financial disclosures and author roles can be found in the online version of this article.
Letters: New Observation
Subcutaneous insulin-like growth factor-1 treatment in spinocerebellar ataxias: An open label clinical trial†
Version of Record online: 19 OCT 2010
Copyright © 2010 Movement Disorder Society
Volume 26, Issue 2, pages 358–359, 1 February 2011
How to Cite
Arpa, J., Sanz-Gallego, I., Medina-Báez, J., Portela, L. V. C., Jardim, L. B., Torres-Aleman, I. and Saute, J. A. M. (2011), Subcutaneous insulin-like growth factor-1 treatment in spinocerebellar ataxias: An open label clinical trial. Mov. Disord., 26: 358–359. doi: 10.1002/mds.23423
- Issue online: 14 MAR 2011
- Version of Record online: 19 OCT 2010
- Manuscript Accepted: 5 AUG 2010
- Manuscript Revised: 17 JUL 2010
- Manuscript Received: 22 JUN 2010
No abstract is available for this article.